BPG is committed to discovery and dissemination of knowledge
Featured Articles
12/15/2014 9:45:00 AM | Browse: 686 | Download: 1285
Publication Name World Journal of Clinical Oncology
Manuscript ID 7492
Country United States
Received
2013-11-22 07:44
Peer-Review Started
2013-11-22 11:37
To Make the First Decision
2014-02-27 10:16
Return for Revision
2014-03-04 20:39
Revised
2014-03-05 00:38
Second Decision
2014-05-16 17:32
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2014-05-16 17:52
Articles in Press
2014-05-23 09:10
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-07-24 14:19
Publish the Manuscript Online
2014-12-11 14:23
ISSN 2218-4333 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Review
Article Title Role of FDG PET-CT in evaluation of locoregional nodal disease for initial staging of breast cancer
Manuscript Source Invited Manuscript
All Author List Yiyan Liu
Funding Agency and Grant Number
Corresponding Author Yiyan Liu, MD, PhD Assocaite Professor Department of Radiology New Jersey Medical School Rutgers University 150 Bergen Street, H141 Newark, New Jersey 07103 U.S.A liuyl@njms.rutgers.edu
Key Words Breast cancer; FDG PET/CT; Locoregional nodal disease; Axillary lymph node; Internal mammary lymph node
Core Tip The presence and extent of locoregional nodal metastasis at diagnosis is the single most important prognostic factor in breast cancer. The predominant lymphatic drainage pathway from the breast cancer is toward the axilla. FDG PET/CT is a good predictor of axillary disease and correlates well with SLNB. FDG PET/CT may help to identify patients with high axillary lymph node burden who could then move directly to ALND and would not require the additional step of SLNB. However, FDG PET/CT cannot replace SLNB or ALND due to unsatisfactory sensitivity secondary to the limitation of its spatial resolution. The internal mammary node (IMN) involvement is of prognostic significance in breast cancer, and IMN metastasis has been associated with higher rate of distant metastasis and lower overall survival rates. Limited preliminary data indicated that FDG PET/CT plays a role in identification of positive IMN, and it is superior to conventional imaging modalities.
Publish Date 2014-12-11 14:23
Citation Liu Y. Role of FDG PET-CT in evaluation of locoregional nodal disease for initial staging of breast cancer. World J Clin Oncol 2014; 5(5): 982-989
URL http://www.wjgnet.com/2218-4333/full/v5/i5/982.htm
DOI http://dx.doi.org/10.5306/wjco.v5.i5.982
Full Article (PDF) WJCO-5-982.pdf
Full Article (Word) WJCO-5-982.doc
Manuscript File 7492-Review.doc
Answering Reviewers 7492-Answering reviewers.pdf
Copyright License Agreement 7492-Copyright assignment.pdf
Peer-review Report 7492-Peer review(s).pdf
Scientific Editor Work List 7492-Scientific editor work list.pdf